Oxymorphone Extended-Release Tablets and Parathyroid hormone Subcutaneous
Determining the interaction of Oxymorphone Extended-Release Tablets and Parathyroid hormone Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: oxymorphone
Brand name: Opana, Opana ER, Numorphan HCl
Synonyms: Oxymorphone
Generic Name: parathyroid hormone
Brand name: Natpara
Synonyms: Parathyroid hormone, Parathyroid Hormone
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Oxymorphone Extended-Release Tablets-Parcopa
- Oxymorphone Extended-Release Tablets-Paregoric
- Oxymorphone Extended-Release Tablets-Paremyd
- Oxymorphone Extended-Release Tablets-Paremyd Ophthalmic
- Oxymorphone Extended-Release Tablets-Paricalcitol
- Oxymorphone Extended-Release Tablets-Paricalcitol Capsules
- Parathyroid hormone Subcutaneous-Oxymorphone Hydrochloride
- Parathyroid hormone Subcutaneous-Oxymorphone Injection
- Parathyroid hormone Subcutaneous-Oxymorphone Tablets
- Parathyroid hormone Subcutaneous-Oxytocin
- Parathyroid hormone Subcutaneous-Oxytocin Intravenous, Intramuscular
- Parathyroid hormone Subcutaneous-Oxytrol